RNU6-412P

Across TCGA pan-cancer cohorts, RNU6-412P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-412P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-412P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-412P expression acts as an unfavorable survival marker.

KIRC, STAD, and BRCA are the cancer types where RNU6-412P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.127	0.806	<.001	144	view →
STAD	OS	Tertile	All	0.061	0.731	<.001	72	view →
BRCA	OS	Tertile	All	0.336	0.924	<.001	72	view →
LGG	DFS	Tertile	All	0.224	0.738	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-412P–KIRC (OS)

Open the KIRC breakdown →